Matteo Canale Biosciences Laboratory Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Biography Publications Institution JoVE Articles Matteo Canale has not added a biography. If you are Matteo Canale and would like to personalize this page please email our Author Liaison for assistance. Publications Prognostic Role of Circulating MiRNAs in Early-Stage Non-Small Cell Lung Cancer Journal of Clinical Medicine. Jan, 2019 | Pubmed ID: 30678026 Radiofrequency Ablation of Hepatocellular Carcinoma: a Meta-analysis of Overall Survival and Recurrence-free Survival OncoTargets and Therapy. 2018 | Pubmed ID: 30323628 Ten Years of Sorafenib in Hepatocellular Carcinoma: Are There Any Predictive And/or Prognostic Markers? World Journal of Gastroenterology. Sep, 2018 | Pubmed ID: 30271080 Frequency of Actionable Alterations in Epidermal Growth Factor Receptor Wild Type Non-small Cell Lung Cancer: Experience of the Wide Catchment Area of Romagna (AVR) Journal of Thoracic Disease. Aug, 2018 | Pubmed ID: 30233859 Circulating Plasma Levels of MiR-20b, MiR-29b and MiR-155 As Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer International Journal of Molecular Sciences. Jan, 2018 | Pubmed ID: 29361687 Immune Checkpoints As a Target for Colorectal Cancer Treatment International Journal of Molecular Sciences. Jun, 2017 | Pubmed ID: 28635639 Обнаружение циркулирующего микроРНК пользовательские группы больных с метастатическим колоректальным раком Matteo Canale1, Giorgia Marisi1, Alessandro Passardi2, Emanuela Scarpi3, Paola Ulivi1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 3Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 58615 Cancer Research
Обнаружение циркулирующего микроРНК пользовательские группы больных с метастатическим колоректальным раком Matteo Canale1, Giorgia Marisi1, Alessandro Passardi2, Emanuela Scarpi3, Paola Ulivi1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 3Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS JoVE 58615 Cancer Research